banner

Dr. rer. nat. Julia Haupt

jhaupt

Biochemistry

Researcher

Field of Activity

Signal Transduction

Telephone +49-30-838-54779
Email juliahaupt (at) zedat.fu-berlin.de
  • Haupt J, Deichsel A, Stange K, Ast C, Bocciardi R, Ravazzolo R, Di Rocco M, Ferrari P, Landi A, Kaplan FS, Shore EM, Reissner C, Seemann P. (2014). ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant. Hum Mol Genet. 23 (20), 5364-5377.
  • Stricker S, Mathia S, Haupt J, Seemann P, Meier J, Mundlos S. (2011). Odd-skipped related genes regulate differentiation of embryonic limb mesenchyme and bone marrow mesenchymal stromal cells. Stem Cells Dev.; 21(4):623-33.
  • Kaplan FS, Seemann P, Haupt J, Xu M, Lounev VY, Mullins M, Shore EM. (2010). Investigations of activated ACVR1/ALK2, a bone morphogenetic protein type I receptor, that causes fibrodysplasia ossificans progressiva. Methods Enzymol.;484:357-73.
  • Villavicencio-Lorini P, Kuss P, Friedrich J, Haupt J, Farooq M, Türkmen S, Duboule D, Hecht J, Mundlos S. (2010). Homeobox genes d11-d13 and a13 control mouse autopod cortical bone and joint formation. J Clin Invest.;120(6):1994-2004.
  • Seemann P, Brehm A, Konig J, Reissner C, Stricker S, Kuss P, Haupt J, Renninger S, Nickel J, Sebald W, Groppe JC, Ploger F, Pohl J, Schmidt-von Kegler M, Walther M, Gassner I, Rusu C, Janecke AR, Dathe K, Mundlos S. (2010). Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN. PLoS Genet.;5(11):e1000747.
  • Shen Q, Little SC, Xu M, Haupt J, Ast C, Katagiri T, Mundlos S, Seemann P, Kaplan FS, Mullins MC, Shore EM. (2009). The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J Clin Invest.;119(11):3462-72.
  • Stricker S, Brieske N, Haupt J, Mundlos S. (2006). Comparative expression pattern of Odd-skipped related genes Osr1 and Osr2 in chick embryonic development. Gene Expr Patterns.;6(8):826-34.